Moderna Inc MRNA -11.5% Get Free Report shares were down 13.5% at $26.88 and Novavax Inc NVAX -9.02% Get Free Report shares ...
Vaccine makers Moderna Inc (NASDAQ:MRNA) and Novavax Inc (NASDAQ:NVAX) are facing selling pressure on Wednesday following reports suggesting the Trump administration will end support for Gavi.
But Bloomberg reported that the Trump administration was weighing whether to pull funding for an mRNA bird flu vaccine being developed by Moderna. Chickens can be vaccinated against bird flu ...
Moderna’s Bird Flu Vaccine Faces Uncertainty Moderna is facing potential financial difficulties, as the Trump administration is considering canceling a $590 million contract for the company’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results